New Data Reveals Metformin’s Role in Early Pregnancy Success – Fertility Plus
Fertility Plus shared a post on LinkedIn:
“Don’t Stop Metformin at a Positive Test: New Data Shows Continuing Through Trimester 1 Cut Miscarriage Risk in Half
A massive new systematic review and meta-analysis published in the American Journal of Obstetrics and Gynaecology analysed data from over 1,700 women to settle the debate on metformin timing. The results showed that continuing metformin through the first trimester significantly boosted clinical pregnancy rates and reduced the odds of miscarriage by over 50% compared to stopping immediately upon confirmation. Researchers propose that abrupt stopping causes a harmful ‘insulin rebound’ effect during critical early fetal development.
A systematic review and meta-analysis of 12 Randomized Controlled Trials (n=1,708) published in the American Journal of Obstetrics and Gynecology.”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Oct 11, 2025, 06:44The Global IVF Market Is Set to Reach $65B by 2032 – Meddilink
-
Dec 22, 2025, 16:40Innovative Research in IVF Outcomes and Immunology – Lunds Universitet
-
Dec 22, 2025, 16:35AI’s Role in Advancing Women’s Mental Health Explored – Archives of Women’s Mental Health
-
Dec 22, 2025, 16:31Leili Mohebnasab: Why Pregnancy Was Never Designed to Be Easy
-
Dec 22, 2025, 16:21Rachael Menezes: Enhancing Maternal Health Through MMS Implementation
-
Dec 22, 2025, 16:11Gut Microbiota’s Role in Maternal-Fetal Immune Tolerance – Weill Cornell Medicine
-
Dec 22, 2025, 11:34Camille Le Ray: Exploring Maternity Care Challenges and Mental Health Outcomes
-
Dec 22, 2025, 11:29Exploring Epigenetic Advances in Reproductive Biology – Epigenome Technologies
-
Dec 22, 2025, 11:25How Microchimerism Influences Lifelong Health – Microchimerism Community
-
Dec 22, 2025, 11:22Mathew Leonardi: Advancements in Ultrasound and MRI for Endometriosis Diagnosis